Yi Chen
Impact in
- Toxicology top 1%
- Oncology top 5%
- PARP inhibition in cancer therapy
Papers in
- Oncology 40
- PARP inhibition in cancer therapy 9
-
- Cancer therapeutics and mechanisms 17
- Histone Deacetylase Inhibitors Research 16
- Protein Degradation and Inhibitors 11
- Epigenetics and DNA Methylation 11
- DNA Repair Mechanisms 8
- Co-authors
- Jian Ding (53 shared papers)Jian Ping Ding (2 shared papers)Meiyu Geng (26 shared papers)Yu Lei (2 shared papers)Yafang Wang (2 shared papers)Wei Lü (15 shared papers)Yanyan Shen (12 shared papers)Ze‐Hong Miao (11 shared papers)
- Journals
- Acta Pharmacologica Sinica (14 papers)European Journal of Medicinal Chemistry (11 papers)Journal of Medicinal Chemistry (7 papers)Bioorganic & Medicinal Chemistry Letters (7 papers)Bioorganic & Medicinal Chemistry (6 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Yi Chen
130 papers receiving 3.9k citations
Yi Chen's Hit Papers
Peers
Comparison fields: 5 of 142
- Toxicology 143
- Oncology 1.0k
- Molecular Biology 2.1k
- Cancer Research 387
- Organic Chemistry 693
Countries citing papers authored by Yi Chen
This map shows the geographic impact of Yi Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Chen more than expected).
Fields of papers citing papers by Yi Chen
This network shows the impact of papers produced by Yi Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Chen. The network helps show where Yi Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Yi Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 133 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 242 | |
| 2 | 2019 | 154 | |
| 3 | 2016 | 147 | |
| 4 | 2020 | 117 | |
| 5 | 2015 | 113 | |
| 6 | 2011 | 104 | |
| 7 | 2006 | 99 | |
| 8 | 2021 | 98 | |
| 9 | 2016 | 90 | |
| 10 | 2017 | 90 | |
| 11 | 2013 | 81 | |
| 12 | 2006 | 78 | |
| 13 | 2015 | 76 | |
| 14 | 2015 | 72 | |
| 15 | 2013 | 64 | |
| 16 | 2018 | 61 | |
| 17 | 2009 | 60 | |
| 18 | 2016 | 60 | |
| 19 | 2016 | 59 | |
| 20 | 2023 | 57 |
About Yi Chen
Yi Chen is a scholar working on Oncology, Molecular Biology, Hepatology, Toxicology and Cancer Research, having authored 133 papers that have together received 3.9k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (17 papers), Histone Deacetylase Inhibitors Research (16 papers), Protein Degradation and Inhibitors (11 papers), Epigenetics and DNA Methylation (11 papers), PARP inhibition in cancer therapy (9 papers), Liver physiology and pathology (9 papers), DNA Repair Mechanisms (8 papers) and Bioactive Compounds and Antitumor Agents (8 papers). The work is most often cited by research in Toxicology (143 citations), Oncology (1.0k citations), Molecular Biology (2.1k citations), Cancer Research (387 citations) and Organic Chemistry (693 citations). Yi Chen has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Jian Ding, Jian Ping Ding, Meiyu Geng, Yu Lei, Yafang Wang, Wei Lü, Yanyan Shen, Ze‐Hong Miao, Qin Xie and Linjiang Tong. Their work appears in journals such as Acta Pharmacologica Sinica, European Journal of Medicinal Chemistry, Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters and Bioorganic & Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.